RD3 Antibodies

Santa Cruz Biotechnology features a diverse variety of RD3 Antibodies for advanced research in molecular biology. RD3 Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RD3, or Retinal Degeneration 3, plays a critical role in maintaining photoreceptor cells in the retina. RD3 function is essential for visual signal transduction, and mutations in the RD3 gene have been linked to retinal degenerative diseases. Understanding RD3 in cellular processes is crucial for developing therapeutic strategies for vision-related disorders. Researchers worldwide rely on RD3 monoclonal antibodies to investigate retinal development and disease progression. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization of RD3 expression patterns. Ongoing studies of RD3 continue to reveal new insights into retinal biology and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for RD3 research support scientists in their mission to advance understanding of vision disorders and develop innovative treatments.